Clinical Profile and Outcome of Conservatively Managed Emphysematous Pyelonephritis

Table 1

Clinical profile and outcome of patients with EPN.

Patient	1	2	3	4	5	6	7	8
Gender/age (yr)	M/54	F/52	M/33	F/53	F/55	M/58	M/38	F/54
Duration of diabetes (yr)	18	10	4	5	8	12	5	6
Fever	+	+	+	+	+	+	+	+
Loin pain	+	+	+	+	+	+	+	+
Oliguria	+	+	−	+	−	+	+	+
Dysuria	+	+	+	+	+	+	+	+
Serum creatinine at admission (mg/dL)	7	7.7	2.3	7.8	2.7	5.8	3.1	7.4
Serum creatinine at discharge (mg/dL)	3.3	3.24	1.8	2.6	1.6	1.7	1.8	3.2
Urine culture	E. coli	E. coli	E. coli	E. coli	E. coli	E. coli	E. coli	E. coli
Blood culture	Sterile	Sterile	Sterile	Sterile	Sterile	Sterile	Sterile	Sterile
Laterality	Bilateral	Bilateral	Unilateral	Bilateral	Unilateral	Bilateral	Unilateral	Unilateral
Huang et al. CT-scan staging	4	4	3A	4	1	4	2	2
Hemodialysis sessions	4	4	0	3	0	4	0	4
Hydronephrosis	Yes	No	No	Yes	No	Yes	No	Yes
DJ stent	Yes	No	No	Yes	No	Yes	No	Yes
Duration of DJ stent (days)	10	−	−	14	−	14	−	12
Recurrence of obstruction	No	−	−	No	−	No	−	No
Antibiotics used	IME	IME	IME	Pip + Tz	Cef + Slb	IME	Cef + Slb	IME
Duration of antibiotics (days)	10	14	10	14	14	10	14	10

IME: Imipenem, Pip + Tz: Piperacillin + Tazobactam, Cef + Slb: Cefoperazone + Sulbactam.